FY2025
Effective from
- Inherited rules changed
Type 2 diabetes mellitus with other diabetic ophthalmic complication
Billable diagnosis code
CDC/NCHS · FY2025Coverage depends on the payer, service and applicable policy. A billable code does not guarantee payment.
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2015-10-01
Latest recorded change · FY2025
Effective from
Type 2 diabetes mellitus with other diabetic ophthalmic complication
Billable diagnosis code
CDC/NCHS · FY2025| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | Inherited rules changed |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | Inherited rules changed |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Historical mapping only; not an automatic code substitution.
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Other entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| E11.31 | Type 2 diabetes mellitus with unspecified diabetic retinopathy | Category · further specificity required |
| E11.32 | Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy | Category · further specificity required |
| E11.33 | Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy | Category · further specificity required |
| E11.34 | Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy | Category · further specificity required |
| E11.35 | Type 2 diabetes mellitus with proliferative diabetic retinopathy | Category · further specificity required |
| E11.36 | Type 2 diabetes mellitus with diabetic cataract | Billable / specific |
| E11.37 | Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment | Category · further specificity required |
Official titles and instructions are preserved in their source language. Official sources ↗